Subscribe or Manage Preferences

Personalized Medicine in Rheumatology

Risk is related to many disease factors, including comorbidities and increased age By Alice Goodman Patients with rheumatoid arthritis (RA) are at increased risk for infection. Researchers at the Mayo Clinic have developed a new risk score that can predict the risk of serious infection in patients with RA. The risk score was validated in a recent study in 2 cohorts of patients with RA (Crowson CS, et al. Arthritis Rheum. 2012;64:2847-2855).
By Sy Schlager, MD, PhD The effective use of biologic disease-modifying antirheumatic drugs (DMARDs) has dramatically improved the treatment of rheumatoid arthritis (RA) over recent years.
By Sy Schlager, MD, PhD

Belimumab (Benlysta) has recently been approved in the United States for the treatment of systemic lupus erythematosus (SLE), with a specific indication for use in adult patients with active, autoantibody-positive disease who are currently receiving standard therapies. However, the optimal use of this agent in SLE has not been well defined.

Page 3 of 3
Results 21 - 23 of 23
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology